Roivant Sciences Correlations

ROIV Stock

USD 12.71 0.02 0.16%

The current 90-days correlation between Roivant Sciences and Krystal Biotech is 0.46 (i.e., Very weak diversification). The correlation of Roivant Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Roivant Sciences Correlation With Market

Weak diversification

The correlation between Roivant Sciences and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Moving together with Roivant Stock

0.68

DYAI

Dyadic International

Pair Corr

Moving against Roivant Stock

0.35

VRDN

Viridian Therapeutics

Pair Corr

Related Correlations Analysis

	KRYS	RXDX	AKRO	APLS	DAWN	PHAT	BPMC	LYRA	CGEM
KRYS		-0.39	-0.09	0.7	-0.01	-0.1	0.38	0.28	0.17	KRYS
RXDX	-0.39		0.73	-0.8	0.21	-0.52	0.18	-0.62	-0.68	RXDX
AKRO	-0.09	0.73		-0.57	0.54	-0.38	0.54	-0.33	-0.55	AKRO
APLS	0.7	-0.8	-0.57		-0.2	0.25	0.03	0.53	0.52	APLS
DAWN	-0.01	0.21	0.54	-0.2		0.26	0.26	0.33	0.25	DAWN
PHAT	-0.1	-0.52	-0.38	0.25	0.26		-0.41	0.75	0.77	PHAT
BPMC	0.38	0.18	0.54	0.03	0.26	-0.41		-0.07	-0.25	BPMC
LYRA	0.28	-0.62	-0.33	0.53	0.33	0.75	-0.07		0.83	LYRA
CGEM	0.17	-0.68	-0.55	0.52	0.25	0.77	-0.25	0.83		CGEM
	KRYS	RXDX	AKRO	APLS	DAWN	PHAT	BPMC	LYRA	CGEM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CGEM	+ 0.83	LYRA
CGEM	+ 0.77	PHAT
LYRA	+ 0.75	PHAT
AKRO	+ 0.73	RXDX
APLS	+ 0.7	KRYS
DAWN	+ 0.54	AKRO

High negative correlations

APLS	- 0.8	RXDX
CGEM	- 0.68	RXDX
LYRA	- 0.62	RXDX
APLS	- 0.57	AKRO
CGEM	- 0.55	AKRO
PHAT	- 0.52	RXDX

Risk-Adjusted Indicators

There is a big difference between Roivant Stock performing well and Roivant Sciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Roivant Sciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KRYS	1.77	(0.23)	0.00	(0.02)	0.00	0.00	4.45	(3.75)	12.05
RXDX	2.40	1.08	0.49	(2.44)	0.76	(2.61)	2.76	(3.26)	70.71
AKRO	2.37	0.09	0.07	0.17	2.62	(2.49)	5.23	(4.45)	13.37
APLS	2.47	(0.21)	0.00	(0.21)	0.00	0.00	4.48	(5.17)	15.97
DAWN	2.06	(0.09)	(0.04)	0.01	2.77	(1.91)	3.84	(3.69)	11.44
PHAT	3.76	(0.77)	0.00	(2.74)	0.00	0.00	6.89	(6.83)	35.62
BPMC	1.82	(0.08)	(0.02)	0.06	2.57	(1.71)	4.90	(3.62)	14.28
LYRA	4.22	(0.60)	0.00	(0.31)	0.00	0.00	10.53	(10.00)	41.07
CGEM	2.89	(0.71)	0.00	(0.21)	0.00	0.00	5.88	(7.24)	17.85

Roivant Sciences Corporate Management

Amy Mahery	Chief Officer	Profile
Matthew Gline	CEO Director	Profile
Marianne Romeo	Head Management	Profile
Huafeng Xu	Chief Officer	Profile
Josh Chen	General Counsel	Profile
Matt Maisak	Chief Platforms	Profile
Vivek Ramaswamy	Founder Chairman	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC